10-Q//Quarterly update
ImmunoBiotics Inc 10-Q
Accession 0001213900-09-001321
CIK 0001413579operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 3:18 PM ET
Size
427.3 KB
Accession
0001213900-09-001321
Documents
- 10-Qf10q0309_immuno.htmPrimary
QUARTERLY REPORT FOR THE PERIOD ENDING 03/09
- EX-31.1f10q0309ex31i_immuno.htm
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER, PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
- EX-31.2f10q0309ex31ii_immuno.htm
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER, PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
- EX-32.1f10q0309ex32i_immuno.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
- EX-32.2f10q0309ex32ii_immuno.htm
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
Issuer
ImmunoBiotics, Inc.
CIK 0001413579
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001413579
Filing Metadata
- Form type
- 10-Q
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 3:18 PM ET
- Size
- 427.3 KB